| Description of Facilities in 2008 Calibration Dataset | Quantity |
| Facilities |
N=617 |
| Regions |
|
| Midwest |
169 (27.44%) |
| Northeast |
70 (11.36%) |
| South |
274 (44.48%) |
| West |
103 (16.72%) |
| Teaching Status |
|
| Teaching |
286 (46.8%) |
| Non-Teaching |
325 (53.2%) |
| Bed-size |
|
| <100 beds |
134 (21.9%) |
| 100-200 beds |
133(21.8%) |
| 201-300 beds |
119 (19.5%) |
| 301-400 beds |
90 (14.7%) |
| 401-500 beds |
39 (6.4%) |
| 500-600 beds |
25 (4.1%) |
| >600 beds |
71 (11.6%) |
| Average bed-size |
293 Beds |
| Discharges |
|
| Average # of discharge |
22,414 |
| Total Discharges |
14,454,473 |
| Diag |
Description |
% Cases |
Mortality |
Morbidity |
Complications |
| Rate |
Factors |
FIT |
Rate |
Factors |
FIT |
Rate |
Factors |
FIT |
| 008 |
Infct, intestinal d/t oth organisms |
0.48% |
1.7% |
24 |
0.094 |
9.9% |
39 |
0.492 |
30.5% |
37 |
0.388 |
| 038 |
Septicemia |
1.42% |
18.2% |
58 |
0.223 |
31.5% |
69 |
0.670 |
64.7% |
76 |
0.459 |
| 042 |
HIV disease |
0.16% |
7.0% |
22 |
0.184 |
25.3% |
35 |
0.356 |
47.9% |
34 |
0.305 |
| 151 |
Neoplasm, Malignant, stomach |
0.06% |
9.4% |
29 |
0.195 |
22.0% |
35 |
0.324 |
58.4% |
33 |
0.301 |
| 153 |
Neoplasm, Malignant, colon |
0.29% |
4.6% |
47 |
0.152 |
21.5% |
45 |
0.389 |
50.7% |
51 |
0.345 |
| 154 |
Neoplasm, Malignant, rectum/anus |
0.12% |
3.5% |
34 |
0.122 |
13.4% |
38 |
0.426 |
48.5% |
49 |
0.314 |
| 157 |
Neoplasm, Malignant, pancreas |
0.10% |
11.1% |
30 |
0.189 |
14.3% |
28 |
0.373 |
49.4% |
35 |
0.320 |
| 162 |
Neop, mlig, trachea/bronchus/lung |
0.43% |
12.3% |
40 |
0.208 |
24.7% |
40 |
0.267 |
49.3% |
45 |
0.319 |
| 174 |
Neoplasm, Malignant, female breast |
0.21% |
2.1% |
29 |
0.237 |
2.7% |
28 |
0.367 |
15.9% |
37 |
0.277 |
| 182 |
Neoplasm, Malignant, body, uterus |
0.11% |
1.2% |
23 |
0.129 |
6.4% |
25 |
0.458 |
33.8% |
27 |
0.298 |
| 183 |
Neop, mlig, ovary/uterine adnexa |
0.08% |
5.2% |
22 |
0.211 |
11.8% |
29 |
0.423 |
47.5% |
37 |
0.330 |
| 185 |
Neoplasm, Malignant, prostate |
0.25% |
1.1% |
24 |
0.220 |
5.5% |
22 |
0.217 |
23.3% |
33 |
0.280 |
| 188 |
Neoplasm, Malignant, bladder |
0.10% |
3.3% |
27 |
0.143 |
12.1% |
35 |
0.500 |
41.0% |
34 |
0.415 |
| 189 |
Neop, Mlig, kdny/oth urinary organ |
0.13% |
2.2% |
32 |
0.140 |
10.2% |
28 |
0.473 |
41.1% |
37 |
0.342 |
| 191 |
Neoplasm, Malignant, brain |
0.09% |
4.6% |
24 |
0.170 |
7.0% |
28 |
0.407 |
34.8% |
30 |
0.371 |
| 197 |
Neoplasm, metastatic, rsprt/dgstv |
0.35% |
13.0% |
42 |
0.148 |
15.4% |
35 |
0.362 |
44.6% |
48 |
0.384 |
| 198 |
Neoplasm, Metastatic, other sites |
0.29% |
7.3% |
36 |
0.123 |
9.5% |
36 |
0.369 |
39.6% |
56 |
0.384 |
| 202 |
Neop, mlig,lymphoid/
histiocytic |
0.09% |
10.7% |
28 |
0.194 |
16.9% |
33 |
0.420 |
49.5% |
36 |
0.368 |
| 250 |
Diabetes mellitus |
1.29% |
0.9% |
31 |
0.078 |
10.4% |
61 |
0.611 |
37.6% |
68 |
0.431 |
| 276 |
Dsord, fluid/elctrlyt/
acid-base bal |
1.17% |
2.0% |
34 |
0.075 |
8.4% |
50 |
0.535 |
36.5% |
52 |
0.357 |
| 280 |
Anemias, iron deficiency |
0.19% |
0.5% |
14 |
0.040 |
4.6% |
25 |
0.305 |
35.6% |
33 |
0.222 |
| 282 |
Anemias, hereditary hemolytic |
0.20% |
0.4% |
13 |
0.056 |
6.4% |
22 |
0.412 |
30.2% |
27 |
0.247 |
| 285 |
Anemia, other & unspecified |
0.20% |
1.3% |
23 |
0.041 |
5.8% |
32 |
0.332 |
37.8% |
36 |
0.248 |
| 288 |
Diseases of white blood cells |
0.13% |
2.3% |
22 |
0.091 |
7.9% |
35 |
0.345 |
46.9% |
38 |
0.326 |
| 295 |
Disorders, schizophrenic |
0.71% |
0.0% |
14 |
0.003 |
1.0% |
27 |
0.283 |
14.3% |
48 |
0.220 |
| 296 |
Psychoses, affective |
1.82% |
0.0% |
18 |
0.002 |
1.0% |
38 |
0.299 |
13.9% |
59 |
0.250 |
| 304 |
Dependence, drug |
0.18% |
0.0% |
11 |
0.023 |
0.6% |
21 |
0.229 |
9.9% |
39 |
0.236 |
| 331 |
Degeneration, other cerebral |
0.21% |
2.0% |
28 |
0.129 |
6.1% |
31 |
0.409 |
35.7% |
44 |
0.325 |
| 345 |
Epilepsy |
0.18% |
1.1% |
18 |
0.096 |
9.7% |
17 |
0.552 |
31.0% |
46 |
0.437 |
| 348 |
Brain conditions, other |
0.14% |
7.7% |
30 |
0.392 |
16.4% |
35 |
0.586 |
50.4% |
50 |
0.457 |
| 398 |
Disease, other rheumatic heart |
0.10% |
4.7% |
18 |
0.125 |
16.3% |
22 |
0.321 |
49.7% |
34 |
0.265 |
| 401 |
Hypertension, essential |
0.24% |
0.3% |
17 |
0.062 |
4.2% |
34 |
0.488 |
39.3% |
30 |
0.199 |
| 410 |
Acute myocardial infarction |
1.86% |
5.9% |
47 |
0.231 |
29.4% |
68 |
0.600 |
54.7% |
76 |
0.433 |
| 411 |
Disease, other acute ischemic heart |
0.10% |
0.4% |
12 |
0.036 |
7.5% |
39 |
0.440 |
26.2% |
31 |
0.358 |
| 413 |
Angina pectoris |
0.05% |
0.1% |
10 |
0.011 |
2.3% |
11 |
0.214 |
21.0% |
23 |
0.247 |
| 414 |
Disease, oth chronic ischemic heart |
3.26% |
0.6% |
36 |
0.076 |
9.6% |
48 |
0.369 |
34.9% |
64 |
0.386 |
| 415 |
Disease, acute pulmonary heart |
0.42% |
3.6% |
27 |
0.204 |
16.0% |
35 |
0.505 |
45.6% |
46 |
0.350 |
| 424 |
Diseases, endocardium, other |
0.21% |
3.4% |
24 |
0.179 |
28.0% |
44 |
0.324 |
62.8% |
48 |
0.345 |
| 425 |
Cardiomyopathy |
0.08% |
2.5% |
32 |
0.233 |
6.0% |
33 |
0.315 |
30.6% |
31 |
0.297 |
| 426 |
Disorder, conduction |
0.16% |
1.5% |
35 |
0.125 |
11.9% |
32 |
0.585 |
33.2% |
49 |
0.413 |
| 427 |
Dysrhythmias, cardiac |
1.92% |
2.1% |
38 |
0.436 |
8.9% |
49 |
0.629 |
30.9% |
61 |
0.401 |
| 428 |
Failure, heart |
2.57% |
3.4% |
49 |
0.111 |
14.4% |
49 |
0.444 |
54.3% |
59 |
0.335 |
| 430 |
Hemorrhage, subarachnoid |
0.08% |
23.1% |
29 |
0.361 |
31.1% |
29 |
0.506 |
57.9% |
34 |
0.444 |
| 431 |
Hemorrhage, intracerebral |
0.20% |
28.0% |
31 |
0.340 |
27.4% |
37 |
0.467 |
56.0% |
42 |
0.358 |
| 432 |
Hemorrhage, intracranial |
0.09% |
16.0% |
24 |
0.350 |
20.0% |
31 |
0.487 |
49.5% |
41 |
0.416 |
| 433 |
Oclsn/stenosis, precerebral artery |
0.51% |
1.2% |
16 |
0.146 |
5.2% |
41 |
0.337 |
25.5% |
53 |
0.308 |
| 434 |
Occlusion, cerebral arteries |
1.04% |
5.7% |
34 |
0.163 |
12.6% |
44 |
0.482 |
43.6% |
50 |
0.376 |
| 435 |
Ischemia, transient cerebral |
0.48% |
0.2% |
15 |
0.010 |
2.7% |
33 |
0.281 |
25.4% |
40 |
0.280 |
| 436 |
Disease, acute cerbvas, ill-defined |
0.01% |
5.8% |
12 |
0.162 |
5.7% |
10 |
0.413 |
32.8% |
13 |
0.359 |
| 440 |
Atherosclerosis |
0.47% |
1.8% |
34 |
0.124 |
10.6% |
46 |
0.550 |
36.5% |
58 |
0.359 |
| 441 |
Aneurysm and dissection, aortic |
0.22% |
8.8% |
42 |
0.281 |
23.2% |
48 |
0.498 |
52.2% |
73 |
0.405 |
| 444 |
Embolism and thrombosis, arterial |
0.10% |
4.0% |
31 |
0.167 |
15.4% |
39 |
0.536 |
44.5% |
49 |
0.376 |
| 453 |
Embolism/thrombosis, venous, other |
0.38% |
1.0% |
24 |
0.054 |
8.0% |
39 |
0.449 |
31.5% |
47 |
0.385 |
| 458 |
Hypotension |
0.27% |
1.9% |
23 |
0.145 |
7.5% |
30 |
0.378 |
44.9% |
40 |
0.246 |
| 466 |
Bronchitis and bronchiolitis, acute |
0.40% |
0.1% |
15 |
0.035 |
7.7% |
22 |
0.054 |
23.4% |
28 |
0.174 |
| 480 |
Pneumonia, viral |
0.05% |
0.8% |
14 |
0.105 |
6.7% |
22 |
0.446 |
27.6% |
25 |
0.336 |
| 481 |
Pneumonia d/t pneumococcal virus |
0.06% |
2.8% |
19 |
0.141 |
16.2% |
30 |
0.553 |
51.4% |
29 |
0.317 |
| 482 |
Pneumonia, other bacterial |
0.23% |
6.6% |
35 |
0.114 |
22.9% |
47 |
0.409 |
61.2% |
48 |
0.314 |
| 486 |
Pneumonia, organism NOS |
2.16% |
3.5% |
34 |
0.096 |
10.9% |
46 |
0.441 |
46.9% |
57 |
0.299 |
| 491 |
Bronchitis, chronic |
1.13% |
1.9% |
35 |
0.074 |
16.0% |
44 |
0.436 |
45.8% |
51 |
0.289 |
| 493 |
Asthma |
0.95% |
0.3% |
24 |
0.104 |
9.7% |
35 |
0.126 |
27.3% |
44 |
0.199 |
| 496 |
Obstruction, chronic airway NEC |
0.04% |
7.4% |
19 |
0.320 |
15.6% |
19 |
0.461 |
47.1% |
31 |
0.309 |
Return to Article Contents
Proceed to Next Section
|
540 Gaither Road Rockville, MD 20850 